Peripheral nerve function in sepsis and multiple organ failure.

PubWeight™: 2.46‹?› | Rank: Top 2%

🔗 View Article (PMID 1845860)

Published in Chest on January 01, 1991

Authors

N J Witt1, D W Zochodne, C F Bolton, F Grand'Maison, G Wells, G B Young, W J Sibbald

Author Affiliations

1: Department of Clinical Neurological Sciences, University of Western Ontario, London, Canada.

Articles citing this

Effectiveness and safety of the awakening and breathing coordination, delirium monitoring/management, and early exercise/mobility bundle. Crit Care Med (2014) 3.46

Reducing iatrogenic risks: ICU-acquired delirium and weakness--crossing the quality chasm. Chest (2010) 2.28

Increased duration of mechanical ventilation is associated with decreased diaphragmatic force: a prospective observational study. Crit Care (2010) 1.85

Intensive care unit-acquired neuromyopathy and corticosteroids in survivors of persistent ARDS. Intensive Care Med (2008) 1.76

Sepsis-induced myopathy. Crit Care Med (2009) 1.72

Clinical review: Critical illness polyneuropathy and myopathy. Crit Care (2008) 1.69

Bench-to-bedside review: mobilizing patients in the intensive care unit--from pathophysiology to clinical trials. Crit Care (2009) 1.49

Role of endotoxin in the pathogenesis of critical illness polyneuropathy. J Neurol (2008) 1.39

Clinical review: Sleep measurement in critical care patients: research and clinical implications. Crit Care (2007) 1.31

Simplified electrophysiological evaluation of peripheral nerves in critically ill patients: the Italian multi-centre CRIMYNE study. Crit Care (2007) 1.27

The Sick and the Weak: Neuropathies/Myopathies in the Critically Ill. Physiol Rev (2015) 1.20

Risk factors for critical illness polyneuromyopathy. J Neurol (2005) 1.16

Clinical review: intensive care unit acquired weakness. Crit Care (2015) 1.01

Critical illness polyneuropathy and myopathy in the intensive care unit. Nat Rev Neurol (2009) 1.01

Validation of the peroneal nerve test to diagnose critical illness polyneuropathy and myopathy in the intensive care unit: the multicentre Italian CRIMYNE-2 diagnostic accuracy study. F1000Res (2014) 1.01

Difficult weaning. Intensive Care Med (1993) 0.99

Mechanisms of neuromuscular dysfunction in critical illness. Crit Care Clin (2008) 0.99

Benefits of intensive insulin therapy on neuromuscular complications in routine daily critical care practice: a retrospective study. Crit Care (2009) 0.96

Critical illness myopathy and polyneuropathy - A challenge for physiotherapists in the intensive care units. Indian J Crit Care Med (2011) 0.95

Intensive care unit-acquired weakness: implications for physical therapist management. Phys Ther (2012) 0.93

Critical illness neuromuscular disease: clinical, electrophysiological, and prognostic aspects. Arch Dis Child (2002) 0.91

Maximum inspiratory pressure, a surrogate parameter for the assessment of ICU-acquired weakness. BMC Anesthesiol (2011) 0.89

Muscle ultrasound for early assessment of critical illness neuromyopathy in severe sepsis. Crit Care (2013) 0.89

Neuromuscular complications of sepsis. Intensive Care Med (1993) 0.88

Critical illness polyneuropathy and myopathy: a systematic review. Neural Regen Res (2014) 0.88

Neuromuscular deterioration in the early stage of sepsis in rats. Crit Care (2007) 0.88

The impact of extended bed rest on the musculoskeletal system in the critical care environment. Extrem Physiol Med (2015) 0.86

Combination of histopathological and electromyographic patterns can help to evaluate functional outcome of critical ill patients with neuromuscular weakness syndromes. Crit Care (2004) 0.85

ICU-Acquired Weakness. Chest (2016) 0.84

Early Physical Rehabilitation in the ICU: A Review for the Neurohospitalist. Neurohospitalist (2012) 0.82

Physiological and pharmacologic aspects of peripheral nerve blocks. J Anaesthesiol Clin Pharmacol (2015) 0.82

Acute and long-term dysphagia in critically ill patients with severe sepsis: results of a prospective controlled observational study. Eur Arch Otorhinolaryngol (2014) 0.81

Intensive care unit-related generalized neuromuscular weakness due to critical illness polyneuropathy/myopathy in critically ill patients. J Anesth (2014) 0.80

A stronger approach to weakness in the intensive care unit. Crit Care (2004) 0.79

Alcoholism and critical illness: A review. World J Crit Care Med (2016) 0.79

Critical Illness Polyneuropathy. Curr Treat Options Neurol (2000) 0.79

A fresh look at paralytics in the critically ill: real promise and real concern. Ann Intensive Care (2012) 0.78

Intensive care unit acquired weakness in children: Critical illness polyneuropathy and myopathy. Indian J Crit Care Med (2014) 0.78

Neurological complications of severe illness and prolonged mechanical ventilation. Thorax (1996) 0.78

Impairment of small somatic and autonomic nerve fibres in intensive care unit patients with severe sepsis and critical illness polyneuropathy--a single center controlled observational study. BMC Neurol (2013) 0.78

Early administration of cisatracurium attenuates sepsis-induced diaphragm dysfunction in rats. Inflammation (2015) 0.77

Early treatment with IgM-enriched intravenous immunoglobulin does not mitigate critical illness polyneuropathy and/or myopathy in patients with multiple organ failure and SIRS/sepsis: a prospective, randomized, placebo-controlled, double-blinded trial. Crit Care (2013) 0.77

[Critical illness myopathy and polyneuropathy]. Med Klin Intensivmed Notfmed (2017) 0.77

Effects of sepsis on the neuromuscular blocking actions of d-tubocurarine on rat adductor and abductor laryngeal muscles. J Anesth (2009) 0.76

Neuromuscular blocking drugs: practical aspects of research in the intensive care unit. Intensive Care Med (1993) 0.76

Reversible tetraplegia after percutaneous nephrostolithotomy and septic shock: a case of critical illness polyneuropathy and myopathy with acute onset and complete recovery. BMC Nephrol (2013) 0.75

Review of Critical Illness Myopathy and Neuropathy. Neurohospitalist (2016) 0.75

Pharmacology, selection and complications associated with neuromuscular blocking drugs in ICU patients. Yale J Biol Med (2000) 0.75

Intensive care. Postgrad Med J (1993) 0.75

Critical illness polyneuropathy. Chest (1991) 0.75

Critical illness polyneuropathy and myopathy are common neuromuscular complications secondary to sepsis. Neurol Sci (2012) 0.75

Therapeutic effect of insulin in reducing critical illness; polyneuropathy and myopathy in the pediatric intensive care unit. Iran J Child Neurol (2012) 0.75

Critical illness polyneuropathy after septic peritonitis in a boy with nephrotic syndrome. Pediatr Nephrol (2010) 0.75

The incidence of intensive care unit-acquired weakness syndromes: A systematic review. J Intensive Care Soc (2014) 0.75

Peripheral nerve conduction abnormalities precede morphological alterations in an experimental rat model of sepsis. J Anesth (2016) 0.75

Articles by these authors

Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest (1992) 47.46

A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. N Engl J Med (1999) 20.31

Multiple organ dysfunction score: a reliable descriptor of a complex clinical outcome. Crit Care Med (1995) 10.29

Combination therapy with cyclosporine and methotrexate in severe rheumatoid arthritis. The Methotrexate-Cyclosporine Combination Study Group. N Engl J Med (1995) 6.23

Practice parameter: prediction of outcome in comatose survivors after cardiopulmonary resuscitation (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology (2006) 5.24

Users' guides to the medical literature. V. How to use an article about prognosis. Evidence-Based Medicine Working Group. JAMA (1994) 4.49

The ACCP-SCCM consensus conference on sepsis and organ failure. Chest (1992) 4.35

Is a low transfusion threshold safe in critically ill patients with cardiovascular diseases? Crit Care Med (2001) 3.65

Viscosupplementation for the treatment of osteoarthritis of the knee. Cochrane Database Syst Rev (2006) 3.65

A randomized trial comparing octylcyanoacrylate tissue adhesive and sutures in the management of lacerations. JAMA (1997) 3.26

Effect of stored-blood transfusion on oxygen delivery in patients with sepsis. JAMA (1993) 3.23

Glucosamine therapy for treating osteoarthritis. Cochrane Database Syst Rev (2005) 3.00

Factors predicting response to treatment in rheumatoid arthritis: the importance of disease duration. Arthritis Rheum (2000) 2.92

Definitions for sepsis and organ failure. Crit Care Med (1992) 2.69

Sedation in the intensive care unit: a systematic review. JAMA (2000) 2.65

Exercise for preventing and treating osteoporosis in postmenopausal women. Cochrane Database Syst Rev (2002) 2.65

Intraarticular corticosteroid for treatment of osteoarthritis of the knee. Cochrane Database Syst Rev (2006) 2.59

ACR and EULAR improvement criteria have comparable validity in rheumatoid arthritis trials. American College of Rheumatology European League of Associations for Rheumatology. J Rheumatol (1999) 2.58

Meta-analysis of efficacy of quinine for treatment of nocturnal leg cramps in elderly people. BMJ (1995) 2.58

Reporting disease activity in clinical trials of patients with rheumatoid arthritis: EULAR/ACR collaborative recommendations. Ann Rheum Dis (2008) 2.55

Multicentre trial to introduce the Ottawa ankle rules for use of radiography in acute ankle injuries. Multicentre Ankle Rule Study Group. BMJ (1995) 2.50

Laboratory evaluation in the diagnosis of Lyme disease. Ann Intern Med (1997) 2.48

High-dose corticosteroids in patients with the adult respiratory distress syndrome. N Engl J Med (1987) 2.32

Dictated versus database-generated discharge summaries: a randomized clinical trial. CMAJ (1999) 2.28

Contemporary practice patterns in the management of newly diagnosed hypertension. CMAJ (1997) 2.23

Acetaminophen for osteoarthritis. Cochrane Database Syst Rev (2006) 2.21

An acute axonal form of Guillain-Barré polyneuropathy. Brain (1986) 2.20

Warfarin for atrial fibrillation. The patient's perspective. Arch Intern Med (1996) 2.18

Structured exercise improves physical functioning in women with stages I and II breast cancer: results of a randomized controlled trial. J Clin Oncol (2001) 2.16

Phylogenetic characterization of novel transport protein families revealed by genome analyses. Biochim Biophys Acta (1999) 2.15

Polyneuropathy in critically ill patients. J Neurol Neurosurg Psychiatry (1984) 2.14

American Clinical Neurophysiology Society's Standardized Critical Care EEG Terminology: 2012 version. J Clin Neurophysiol (2013) 2.07

Morphological and functional relations of Graafian follicle growth to ovulation in women using ultrasonic, laparoscopic and biochemical measurements. Br J Obstet Gynaecol (1981) 2.06

Prevention of NSAID-induced gastroduodenal ulcers. Cochrane Database Syst Rev (2002) 2.01

Patients readmitted to the intensive care unit during the same hospitalization: clinical features and outcomes. Crit Care Med (1998) 2.00

Preventing perineal trauma during childbirth: a systematic review. Obstet Gynecol (2000) 1.98

Multifocal motor neuropathy improved by IVIg: randomized, double-blind, placebo-controlled study. Neurology (2000) 1.96

Sleep in critically ill patients requiring mechanical ventilation. Chest (2000) 1.95

Effect of noninvasive positive pressure ventilation on mortality in patients admitted with acute respiratory failure: a meta-analysis. Crit Care Med (1997) 1.95

Critically ill polyneuropathy: electrophysiological studies and differentiation from Guillain-Barré syndrome. J Neurol Neurosurg Psychiatry (1986) 1.95

Tissue adhesive versus suture wound repair at 1 year: randomized clinical trial correlating early, 3-month, and 1-year cosmetic outcome. Ann Emerg Med (1998) 1.93

Transfusing red blood cells stored in citrate phosphate dextrose adenine-1 for 28 days fails to improve tissue oxygenation in rats. Crit Care Med (1997) 1.91

Introducing Critical Appraisal to studies of animal models investigating novel therapies in sepsis. Crit Care Med (1996) 1.89

School feeding for improving the physical and psychosocial health of disadvantaged elementary school children. Cochrane Database Syst Rev (2007) 1.88

Do silicone breast implants cause rheumatologic disorders? A systematic review for a court-appointed national science panel. Arthritis Rheum (2001) 1.88

The Southwestern Ontario Joint Replacement Pilot Project: electronic point-of-care data collection. Southwestern Ontario Study Group. Can J Surg (2001) 1.82

Critical illness myopathy. Muscle Nerve (2000) 1.82

Phrenic nerve conduction study in normal subjects. Muscle Nerve (1995) 1.80

Nature, time course and dose dependence of zidovudine-related side effects: results from the Multicenter Canadian Azidothymidine Trial. AIDS (1989) 1.78

Critical illness polyneuropathy. A complication of sepsis and multiple organ failure. Brain (1987) 1.75

Albumin versus hydroxyethyl starch in cardiopulmonary bypass surgery: a meta-analysis of postoperative bleeding. Ann Thorac Surg (2001) 1.74

Refractory neurosarcoidosis responding to infliximab. Neurology (2002) 1.72

Noninvasive positive pressure ventilation in the setting of severe, acute exacerbations of chronic obstructive pulmonary disease: more effective and less expensive. Crit Care Med (2000) 1.71

Clinical improvement as reflected in measures of function and health-related quality of life following treatment with leflunomide compared with methotrexate in patients with rheumatoid arthritis: sensitivity and relative efficiency to detect a treatment effect in a twelve-month, placebo-controlled trial. Leflunomide Rheumatoid Arthritis Investigators Group. Arthritis Rheum (2000) 1.71

Structure and function of neuronal nicotinic acetylcholine receptors. Prog Brain Res (1996) 1.66

Reporting disease activity in clinical trials of patients with rheumatoid arthritis: EULAR/ACR collaborative recommendations. Arthritis Rheum (2008) 1.66

Withdrawal and withholding of life support in the intensive care unit: a comparison of teaching and community hospitals. The Southwestern Ontario Critical Care Research Network. Crit Care Med (1998) 1.65

Looking for important change/differences in studies of responsiveness. OMERACT MCID Working Group. Outcome Measures in Rheumatology. Minimal Clinically Important Difference. J Rheumatol (2001) 1.64

Meta-analysis of treatment termination rates among rheumatoid arthritis patients receiving disease-modifying anti-rheumatic drugs. Rheumatology (Oxford) (2000) 1.64

Etanercept for the treatment of rheumatoid arthritis. Cochrane Database Syst Rev (2003) 1.63

Incidence of acquired demyelination of the CNS in Canadian children. Neurology (2009) 1.63

An analysis of natural scrapie in Suffolk sheep. Heredity (Edinb) (1965) 1.63

Should improvement in rheumatoid arthritis clinical trials be defined as fifty percent or seventy percent improvement in core set measures, rather than twenty percent? Arthritis Rheum (1998) 1.62

Neuromuscular conditions in the intensive care unit. Intensive Care Med (1996) 1.61

Combination treatment of severe rheumatoid arthritis with cyclosporine and methotrexate for forty-eight weeks: an open-label extension study. The Methotrexate-Cyclosporine Combination Study Group. Arthritis Rheum (1997) 1.61

Dopexamine attenuates flow motion in ileal mucosal arterioles in normotensive sepsis. Crit Care Med (1999) 1.60

Fluoride for the treatment of postmenopausal osteoporotic fractures: a meta-analysis. Osteoporos Int (2000) 1.59

Needle electromyography of the diaphragm. Muscle Nerve (1992) 1.59

A Canadian survey of transfusion practices in critically ill patients. Transfusion Requirements in Critical Care Investigators and the Canadian Critical Care Trials Group. Crit Care Med (1998) 1.58

A retrospective review of a large cohort of patients undergoing the process of withholding or withdrawal of life support. Crit Care Med (1997) 1.58

Interobserver variability in data collection of the APACHE II score in teaching and community hospitals. Crit Care Med (1999) 1.57

Clinical utility and cost-effectiveness of an air suspension bed in the prevention of pressure ulcers. JAMA (1993) 1.57

A quantitative study of Meissner's corpuscles in man. Neurology (1966) 1.55

Matrix metalloproteinases degrade myelin basic protein. Neurosci Lett (1995) 1.54

Does implementing pulse oximetry in a critical care unit result in substantial arterial blood gas savings? Chest (1993) 1.54

Improved outcomes in stroke thrombolysis with pre-specified imaging criteria. Can J Neurol Sci (2001) 1.53

Pulmonary artery catheterization. Can there be an integrated strategy for guideline development and research promotion? JAMA (1993) 1.51

When should hypertension be treated? The different perspectives of Canadian family physicians and patients. CMAJ (2000) 1.51

Pulmonary hypertension in sepsis: measurement by the pulmonary arterial diastolic-pulmonary wedge pressure gradient and the influence of passive and active factors. Chest (1978) 1.50

Comparative pharmacology of epibatidine: a potent agonist for neuronal nicotinic acetylcholine receptors. Mol Pharmacol (1995) 1.49

The assessment of the economic return from controlled clinical trials. A framework applied to clinical trials of colorectal cancer follow-up. Eur J Health Econ (2003) 1.49

A randomized controlled trial of strict glycemic control and tertiary level obstetric care versus routine obstetric care in the management of gestational diabetes: a pilot study. Am J Obstet Gynecol (1997) 1.49

A decline in glial cell-line-derived neurotrophic factor expression is associated with impaired regeneration after long-term Schwann cell denervation. Exp Neurol (2002) 1.49

Endotoxin promotes adhesion of human erythrocytes to human vascular endothelial cells under conditions of flow. Crit Care Med (2000) 1.48

Changes in myocardial blood flow rates during hyperdynamic sepsis with induced changes in arterial perfusing pressures and metabolic need. Crit Care Med (1993) 1.47

The neurological consultation and neurological syndromes in the intensive care unit. Baillieres Clin Neurol (1996) 1.47

Nerve biopsy findings in Niemann-Pick type II (NPC) Acta Neuropathol (1994) 1.45

Show me the evidence: a critical appraisal of the Pulmonary Artery Catheter Consensus Conference and other musings on how critical care practitioners need to improve the way we conduct business. Crit Care Med (1997) 1.44

Polymyxin-dextran antiendotoxin pretreatment in an ovine model of normotensive sepsis. Crit Care Med (1997) 1.44

A phase I study of chemically synthesized verotoxin (Shiga-like toxin) Pk-trisaccharide receptors attached to chromosorb for preventing hemolytic-uremic syndrome. J Infect Dis (1995) 1.43

Etidronate for treating and preventing postmenopausal osteoporosis. Cochrane Database Syst Rev (2001) 1.42

CXC chemokines generate age-related increases in neutrophil-mediated brain inflammation and blood-brain barrier breakdown. Curr Biol (1998) 1.41

Decreased capillary density in vivo in bowel mucosa of rats with normotensive sepsis. J Surg Res (1996) 1.41

Solvent-induced collapse of alpha-synuclein and acid-denatured cytochrome c. Protein Sci (2001) 1.40

Intensity of exercise for the treatment of osteoarthritis. Cochrane Database Syst Rev (2003) 1.39

Genetics and disease in domestic animals with particular reference to dairy cattle. Vet Rec (1975) 1.39

The electroencephalogram in sepsis-associated encephalopathy. J Clin Neurophysiol (1992) 1.39